These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8915660)

  • 21. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.
    Hernández-Mijares A; Bañuls C; Gómez-Balaguer M; Bergoglio M; Víctor VM; Rocha M
    Eur J Clin Invest; 2013 Jun; 43(6):549-56. PubMed ID: 23528141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome.
    Usta A; Avci E; Bulbul CB; Kadi H; Adali E
    Reprod Biol Endocrinol; 2018 Apr; 16(1):34. PubMed ID: 29631598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
    Dokras A; Playford M; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Sarwer DB; Allison KC; Coutifaris C; Mehta N; Legro RS
    Clin Endocrinol (Oxf); 2017 May; 86(5):739-746. PubMed ID: 28199736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
    J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
    Chen MJ; Yang WS; Yang JH; Hsiao CK; Yang YS; Ho HN
    Hum Reprod; 2006 Sep; 21(9):2266-71. PubMed ID: 16757555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
    Song do K; Lee H; Sung YA; Oh JY
    Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in adolescents with polycystic ovary syndrome.
    Vrbíková J; Zamrazilová H; Sedláčková B; Šnajderová M
    Gynecol Endocrinol; 2011 Oct; 27(10):820-2. PubMed ID: 20807165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
    Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.
    Phelan N; O'Connor A; Kyaw-Tun T; Correia N; Boran G; Roche HM; Gibney J
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3933-9. PubMed ID: 20519354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
    Li L; Feng Q; Ye M; He Y; Yao A; Shi K
    J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
    Mastorakos G; Koliopoulos C; Creatsas G
    Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
    Joharatnam J; Barber TM; Webber L; Conway GS; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):714-9. PubMed ID: 21521255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles.
    Bousmpoula A; Kouskouni E; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Baka S
    Gynecol Endocrinol; 2018 Feb; 34(2):153-156. PubMed ID: 28937295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.